Efficacy, Safety, and Biomarkers of Single-Agent Bevacizumab Therapy in Patients with Advanced Hepatocellular Carcinoma

OBJECTIVE. Hepatocellular carcinoma (HCC) is a highly vascularized tumor in which neoangiogenesis contributes to growth and metastasis. We assessed the safety, efficacy, and potential biomarkers of activity of bevacizumab in patients with advanced HCC. METHODS. In this phase II trial, eligible patie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Boige, Valérie, Malka, David, Bourredjem, Abderrahmane, Dromain, Clarisse, Baey, Charlotte, Jacques, Nathalie, Pignon, Jean-Pierre, Vimond, Nadege, Bouvet-Forteau, Nathalie, De Baere, Thierry, Ducreux, Michel, Farace, Françoise
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2012
Assuntos:
Hepatobiliary
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3425524/
https://ncbi.nlm.nih.gov/pubmed/22707516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0465
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados